Frequencies of SLC44A2 alleles encoding human neutrophil antigen-3 variants in the African American population

Transfusion

Volumn 52, Issue 5, 2012, Pages 1106-1111

  Huvard, Michael J ^a   Schmid, Pirmin ^a   Stroncek, David F ^a   Flegel, Willy A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIGEN; DNA; HUMAN NEUTROPHIL ANTIGEN 3; HUMAN NEUTROPHIL ANTIGEN 3A ANTIBODY; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; ANTIGEN EXPRESSION; ARTICLE; BLOOD DONOR; CAUCASIAN; CONFIDENCE INTERVAL; FEMALE; FISHER EXACT TEST; GENE; GENE FREQUENCY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; NUCLEOTIDE SEQUENCE; POISSON DISTRIBUTION; REAL TIME POLYMERASE CHAIN REACTION; SLC44A2 GENE; TRANSFUSION RELATED ACUTE LUNG INJURY;

AFRICAN AMERICANS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE FREQUENCY; HUMANS; ISOANTIGENS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; POLYMORPHISM, GENETIC;

EID: 84861100997     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03396.x     Document Type: Article

References (23)

1. Barnard RD,. Indiscriminate transfusion: a critique of case reports illustrating hypersensitivity reactions. N Y State J Med 1951; 51: 2399-402.
2. Popovsky MA, Moore SB,. Diagnostic and pathogenetic considerations in transfusion-related acute lung injury. Transfusion 1985; 25: 573-7.
3. Davoren A, Curtis BR, Shulman IA, Mohrbacher AF, Bux J, Kwiatkowska BJ, McFarland JG, Aster RH,. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities. Transfusion 2003; 43: 641-5.
4. Kleinman S, Caulfield T, Chan P, Davenport R, McFarland J, McPhedran S, Meade M, Morrison D, Pinsent T, Robillard P, Slinger P,. Toward an understanding of transfusion-related acute lung injury: statement of a consensus panel. Transfusion 2004; 44: 1774-89.
5. Bux J,. Antibody-mediated (immune) transfusion-related acute lung injury. Vox Sang 2011; 100: 122-8.
6. Middelburg RA, van Stein D, Briet E, van der Bom JG,. The role of donor antibodies in the pathogenesis of transfusion-related acute lung injury: a systematic review. Transfusion 2008; 48: 2167-76.
7. Reil A, Keller-Stanislawski B, Gunay S, Bux J,. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors. Vox Sang 2008; 95: 313-7.
8. van Leeuwen A, Eernisse JG, van Rood JJ,. A new leucocyte group with two alleles: leucocyte group five. Vox Sang 1964; 9: 431-46.
9. Stroncek DF, Clay M,. Is it time to reconsider neutrophil antibody testing of platelet donors? Transfusion 2011; 51: 2-4.
10. Greinacher A, Wesche J, Hammer E, Furll B, Volker U, Reil A, Bux J,. Characterization of the human neutrophil alloantigen-3a. Nat Med 2010; 16: 45-8.
11. Curtis BR, Cox NJ, Sullivan MJ, Konkashbaev A, Bowens K, Hansen K, Aster RH,. The neutrophil alloantigen HNA-3a (5b) is located on choline transporter-like protein 2 and appears to be encoded by an R>Q154 amino acid substitution. Blood 2010; 115: 2073-6.
12. Curtis BR, Sullivan MJ, Holyst MT, Szabo A, Bougie DW, Aster RH,. HNA-3a-specific antibodies recognize choline transporter-like protein-2 peptides containing arginine, but not glutamine at Position 154. Transfusion 2011; 51: 2168-74.
13. Silliman CC, Stroncek D,. Identification of the HNA-3a antigen. Blood 2010; 115: 1863.
14. Reil A, Wesche J, Greinacher A, Bux J,. Geno- and phenotyping and immunogenicity of HNA-3. Transfusion 2011; 51: 18-24.
15. Flesch BK, Reil A, Bux J,. Genetic variation of the HNA-3a encoding gene. Transfusion 2011; 51: 2391-7.
16. Silliman CC, Curtis BR, Kopko PM, Khan SY, Kelher MR, Schuller RM, Sannoh B, Ambruso DR,. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 2007; 109: 1752-5.
17. Bux J,. Antibody-mediated transfusion-related acute lung injury. Transfusion 2006; 46: 1455-6.
18. Maslanka K, Michur H, Zupanska B, Uhrynowska M, Nowak J,. Leucocyte antibodies in blood donors and a look back on recipients of their blood components. Vox Sang 2007; 92: 247-9.
19. Xia W, Bayat B, Sachs U, Chen Y, Shao Y, Xu X, Deng J, Ding H, Fu Y, Ye X, Santoso S,. The frequencies of human neutrophil alloantigens in the Chinese Han population of Guangzhou. Transfusion 2011; 51: 1271-7.
20. Wilson IG,. Inhibition and facilitation of nucleic acid amplification. Appl Environ Microbiol 1997; 63: 3741-51.
21. Wagner FF, Gassner C, Muller TH, Schonitzer D, Schunter F, Flegel WA,. Molecular basis of weak D phenotypes. Blood 1999; 93: 385-93.
22. Miller LH, Mason SJ, Clyde DF, McGinniss MH,. The resistance factor to Plasmodium vivax in blacks. The Duffy-blood-group genotype, FyFy. N Engl J Med 1976; 295: 302-4.
23. Ozier Y, Muller JY, Mertes PM, Renaudier P, Aguilon P, Canivet N, Fabrigli P, Rebibo D, Tazerout M, Trophilme C, Willaert B, Caldani C,. Transfusion-related acute lung injury: reports to the French Hemovigilance Network 2007 through 2008. Transfusion 2011; 51: 2102-10.